Latest filing published 29 Jan 2020 for Inmune Bio, Inc., €918k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -47.5%Entry US$10.30 · Close at T+365 US$5.41
- -53.8%Entry US$10.92 · Close at T+365 US$5.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Linda F. Powers: trading record in brief
Linda F. Powers has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Northwest Biotherapeutics Inc and Inmune Bio, Inc. In total, 21 filings cover trades dated from 28 May 2010 to 27 January 2020.
The open-market side counts 3 purchases for €549k alongside 14 sales for €2.7M. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2020 alone, the filings show no purchases and 1 sale.
Most recently, on 29 January 2020, the filings show an open-market sale worth €918k in Inmune Bio, Inc. The last purchase on record was published on 5 June 2019, which is 2,713 days ago. Typically, a trade is published a median of 24 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Linda F. Powers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 220,000 shares@ US$4.6062.6% of flowCommon StockSEC:0001104659-20-008253:0
- 10,000 shares@ US$6.003.6% of flowCommon StockSEC:0001640334-19-001052:0Canonical exit: 1 Sept 2019 (T+90)
- 61,667 shares@ US$9.0033.8% of flowCommon StockSEC:0001640334-19-000820:0Canonical exit: 6 Aug 2019 (T+90)
- 804,146 shares@ US$0.1718.3% of flowRestricted Common Stock, par value $0.001SEC:0001144204-19-003609:0
- 3,558,639 shares@ US$0.1781.7% of flowRestricted Common Stock, par value $0.001SEC:0001144204-19-003609:1
- 6,468,153 sharesCommon StockSEC:0001144204-13-000883:0Canonical exit: 12 Mar 2013 (T+90)
- 59,405 sharesCommon StockSEC:0001144204-13-000883:1
- 950,000 shares0Common StockSEC:0001144204-12-041817:0
- 950,000 shares0Common StockSEC:0001144204-11-022197:0
- 950,000 shares0Common StockSEC:0001144204-10-048930:0
- 100,000 shares@ US$1.03Common StockSEC:0001144204-10-037193:0
- 7,900 shares@ US$1.01Common StockSEC:0001144204-10-037193:1
- 32,500 shares@ US$0.97Common StockSEC:0001144204-10-037193:2
- 30,000 shares@ US$0.89Common StockSEC:0001144204-10-037193:3
- 79,000 shares@ US$0.93Common StockSEC:0001144204-10-037193:4
- 20,000 shares@ US$0.82Common StockSEC:0001144204-10-037193:5
- 233,552 shares@ US$0.93Common StockSEC:0001144204-10-037193:6
- 200,000 shares@ US$0.90Common StockSEC:0001144204-10-037193:7
- 7,000 shares@ US$0.91Common StockSEC:0001144204-10-037193:8
- 40,048 shares@ US$0.87Common StockSEC:0001144204-10-037193:9
- 866,667 shares@ US$0.75Common StockSEC:0001144204-10-037193:10
21 of 21 declarations